Kotra's over-the-counter (OTC) products accounted for half of its financial year 2022 revenue, says Kenanga Research.
PETALING JAYA: Kotra Industries Bhd
, which is involved in the pharmaceutical value chain, is expected to continue capitalising on the rising out-of-pocket healthcare expenditure at pharmacies.
According to Kenanga Research, out-of-pocket healthcare spending in Malaysia at private pharmacies delivered a 10-year compound annual growth rate (CAGR) of 11%.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
